Cargando…

Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy

Serotonin (5-HT) regulates important biological and psychological processes including mood, and may be associated with the development of several psychiatric disorders. An association between psychopathology and genes that regulate 5-HT neurotransmission is a robust area of research. Identification...

Descripción completa

Detalles Bibliográficos
Autores principales: Kenna, George A, Roder-Hanna, Nick, Leggio, Lorenzo, Zywiak, William H, Clifford, James, Edwards, Steven, Kenna, John A, Shoaff, Jessica, Swift, Robert M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513226/
https://www.ncbi.nlm.nih.gov/pubmed/23226060
http://dx.doi.org/10.2147/PGPM.S23462
_version_ 1782251905298202624
author Kenna, George A
Roder-Hanna, Nick
Leggio, Lorenzo
Zywiak, William H
Clifford, James
Edwards, Steven
Kenna, John A
Shoaff, Jessica
Swift, Robert M
author_facet Kenna, George A
Roder-Hanna, Nick
Leggio, Lorenzo
Zywiak, William H
Clifford, James
Edwards, Steven
Kenna, John A
Shoaff, Jessica
Swift, Robert M
author_sort Kenna, George A
collection PubMed
description Serotonin (5-HT) regulates important biological and psychological processes including mood, and may be associated with the development of several psychiatric disorders. An association between psychopathology and genes that regulate 5-HT neurotransmission is a robust area of research. Identification of the genes responsible for the predisposition, development, and pharmacological response of various psychiatric disorders is crucial to the advancement of our understanding of their underlying neurobiology. This review highlights research investigating 5-HT transporter (5-HTTLPR) polymorphism, because studies investigating the impact of the 5-HTTLPR polymorphism have demonstrated significant associations with many psychiatric disorders. Decreased transcriptional activity of the S allele (“risk allele”) may be associated with a heightened amygdala response leading to anxiety-related personality traits, major depressive disorder, suicide attempts, and bipolar disorder. By contrast, increased transcriptional activity of the L allele is considered protective for depression but is also associated with completed suicide, nicotine dependence, and attention deficit hyperactivity disorder. For some disorders, such as post-traumatic stress disorder and major depressive disorder, the research suggests that treatment response may vary by allele (such as an enhanced response to serotonin specific reuptake inhibitors in patients with major depressive disorder and post-traumatic stress disorder with L alleles), and for alcohol dependence, the association and treatment for S or L alleles may vary with alcoholic subtype. While some studies suggest that 5-HTTLPR polymorphism can moderate the response to pharmacotherapy, the association between 5-HTTLPR alleles and therapeutic outcomes is inconsistent. The discovery of triallelic 5-HTTLPR alleles (L(A)/L(G)/S) may help to explain some of the conflicting results of many past association studies, while concurrently providing more meaningful data in the future. Studies assessing 5-HTTLPR as the solitary genetic factor contributing to the etiology of psychiatric disorders continue to face the challenges of statistically small effect sizes and limited replication.
format Online
Article
Text
id pubmed-3513226
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-35132262012-12-05 Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy Kenna, George A Roder-Hanna, Nick Leggio, Lorenzo Zywiak, William H Clifford, James Edwards, Steven Kenna, John A Shoaff, Jessica Swift, Robert M Pharmgenomics Pers Med Review Serotonin (5-HT) regulates important biological and psychological processes including mood, and may be associated with the development of several psychiatric disorders. An association between psychopathology and genes that regulate 5-HT neurotransmission is a robust area of research. Identification of the genes responsible for the predisposition, development, and pharmacological response of various psychiatric disorders is crucial to the advancement of our understanding of their underlying neurobiology. This review highlights research investigating 5-HT transporter (5-HTTLPR) polymorphism, because studies investigating the impact of the 5-HTTLPR polymorphism have demonstrated significant associations with many psychiatric disorders. Decreased transcriptional activity of the S allele (“risk allele”) may be associated with a heightened amygdala response leading to anxiety-related personality traits, major depressive disorder, suicide attempts, and bipolar disorder. By contrast, increased transcriptional activity of the L allele is considered protective for depression but is also associated with completed suicide, nicotine dependence, and attention deficit hyperactivity disorder. For some disorders, such as post-traumatic stress disorder and major depressive disorder, the research suggests that treatment response may vary by allele (such as an enhanced response to serotonin specific reuptake inhibitors in patients with major depressive disorder and post-traumatic stress disorder with L alleles), and for alcohol dependence, the association and treatment for S or L alleles may vary with alcoholic subtype. While some studies suggest that 5-HTTLPR polymorphism can moderate the response to pharmacotherapy, the association between 5-HTTLPR alleles and therapeutic outcomes is inconsistent. The discovery of triallelic 5-HTTLPR alleles (L(A)/L(G)/S) may help to explain some of the conflicting results of many past association studies, while concurrently providing more meaningful data in the future. Studies assessing 5-HTTLPR as the solitary genetic factor contributing to the etiology of psychiatric disorders continue to face the challenges of statistically small effect sizes and limited replication. Dove Medical Press 2012-01-13 /pmc/articles/PMC3513226/ /pubmed/23226060 http://dx.doi.org/10.2147/PGPM.S23462 Text en © 2012 Kenna et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Kenna, George A
Roder-Hanna, Nick
Leggio, Lorenzo
Zywiak, William H
Clifford, James
Edwards, Steven
Kenna, John A
Shoaff, Jessica
Swift, Robert M
Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy
title Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy
title_full Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy
title_fullStr Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy
title_full_unstemmed Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy
title_short Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy
title_sort association of the 5-htt gene-linked promoter region (5-httlpr) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513226/
https://www.ncbi.nlm.nih.gov/pubmed/23226060
http://dx.doi.org/10.2147/PGPM.S23462
work_keys_str_mv AT kennageorgea associationofthe5httgenelinkedpromoterregion5httlprpolymorphismwithpsychiatricdisordersreviewofpsychopathologyandpharmacotherapy
AT roderhannanick associationofthe5httgenelinkedpromoterregion5httlprpolymorphismwithpsychiatricdisordersreviewofpsychopathologyandpharmacotherapy
AT leggiolorenzo associationofthe5httgenelinkedpromoterregion5httlprpolymorphismwithpsychiatricdisordersreviewofpsychopathologyandpharmacotherapy
AT zywiakwilliamh associationofthe5httgenelinkedpromoterregion5httlprpolymorphismwithpsychiatricdisordersreviewofpsychopathologyandpharmacotherapy
AT cliffordjames associationofthe5httgenelinkedpromoterregion5httlprpolymorphismwithpsychiatricdisordersreviewofpsychopathologyandpharmacotherapy
AT edwardssteven associationofthe5httgenelinkedpromoterregion5httlprpolymorphismwithpsychiatricdisordersreviewofpsychopathologyandpharmacotherapy
AT kennajohna associationofthe5httgenelinkedpromoterregion5httlprpolymorphismwithpsychiatricdisordersreviewofpsychopathologyandpharmacotherapy
AT shoaffjessica associationofthe5httgenelinkedpromoterregion5httlprpolymorphismwithpsychiatricdisordersreviewofpsychopathologyandpharmacotherapy
AT swiftrobertm associationofthe5httgenelinkedpromoterregion5httlprpolymorphismwithpsychiatricdisordersreviewofpsychopathologyandpharmacotherapy